Investors might want to bet on Werewolf Therapeutics, Inc. (HOWL), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...

Werewolf Therapeutics, Inc. (HOWL) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...

Matthew Galea is a features writer for CBR. He spends his day as a high school English teacher, and every other minute watching, thinking and writing about movies and television. From Lon Chaney Jr.'s ...

) has been revised to $5.30 / share. This is a decrease of 10.86% from the prior estimate of $5.95 dated December 18, 2025. The price target is an average of many targets provided by analysts. The ...

Howling II: Stirba – Werewolf Bitch is a horror-indie film based on Gary Brandner’s novel titled “The Howling II.” In the movie, a man discovers his sister was a werewolf during her funeral. Shocked ...

Award-winning actor Leonardo DiCaprio and respected environmental activist Jane Goodall will executive produce a live-action movie about a dog and young wolf’s survival journey, set to be told through ...

A few weeks back you might recall that we gave you the first heads up on a new werewolf film on the horizon called Howl (“Fever Pitch Ready to Howl” – November 2007). Since that story went up, ...